Hesse et al. reported that sclerostin secreted from breast cancer cells induced muscle fiber atrophy by enhancing NF-κB and p38MAPK signals as well as enhancements of bone destructions by the inhibition of Wnt/β-catenin signals in osteoblasts [96]. This evidence concerns the gene SOST and breast carcinoma.